Cargando…
Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
BACKGROUND AND AIM: Chuanxiong Renshen decoction (CRD) is a traditional Chinese medicine compound used to treat Alzheimer's disease (AD). However, the effects and active ingredients of CRD and its mechanism have not been clarified. We aimed to determine the neuroprotective effects of CRD in a t...
Autores principales: | Shen, Zhuo Jun, Fu, Yun Bo, Hou, Jin Ling, Lin, Lu Ning, Wang, Xiao Yan, Li, Chang Yu, Yang, Yuan Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789652/ https://www.ncbi.nlm.nih.gov/pubmed/36566207 http://dx.doi.org/10.1186/s13020-022-00698-1 |
Ejemplares similares
-
Combination of UPLC–Q-TOF/MS and Network Pharmacology
to Reveal the Mechanism of Qizhen Decoction in the Treatment of Colon
Cancer
por: Kong, Xianbin, et al.
Publicado: (2021) -
Clinical and Basic Research on Renshen Yangrong Decoction
por: Sheng, Wei, et al.
Publicado: (2019) -
Serum Pharmacochemistry Analysis Using UPLC-Q-TOF/MS after Oral Administration to Rats of Shenfu Decoction
por: He, Jia-le, et al.
Publicado: (2015) -
Network pharmacology-based and experimental identification of the effects of Renshen Yangrong decoction on myocardial infarction
por: Zhao, Jiahao, et al.
Publicado: (2022) -
Based on UPLC-Q-TOF-MS/MS, Systematic Network Pharmacology, and Molecular Docking to Explore the Potential Mechanism of Fructus Aurantii for Major Depression Disorder
por: Xie, Yating, et al.
Publicado: (2021)